These provide an advantage above peptide vaccines since they have each HLA course I and II epitopes and as a result are not subject to HLA limits. Additionally, they are able to significantly activate T cells, resulting in an Increased immune response and better T cell activation. Despite the fact https://www.directivepublications.org/journal-of-clinical-breast-cancer/